Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 14Recruiting 9Completed 5Terminated 2Not yet recruiting 2Withdrawn 1Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasm Metastasis 3Oropharyngeal Neoplasms 2Lymphoma, Follicular 2Glioblastoma 2Colorectal Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Lymphoma 1Lung Neoplasms 1Locally Recurrent Skin Squamous Cell Carcinoma 1HTLV-I Infections 1Eyelid Squamous Cell Carcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Breast Carcinoma In Situ 1Astrocytoma 1Anatomic Stage III Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Nivolumab 3taxane 1aldesleukin 1X-Rays 1Specimen Handling 1Phantoms, Imaging 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Interviews as Topic 1Interleukin-2 1E-3810 1CTLA-4 Antigen 1Blood Specimen Collection 1Biopsy 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Ovarian Neoplasms × Magnetic Resonance Spectroscopy × Clear all
NCT04840589 2026-05-13

Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors

National Cancer Institute (NCI)

Phase 1 Suspended
66 enrolled
Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡